These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37116582)

  • 1. Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Pan T; Ji Y; Liu H; Tang B; Song K; Wan X; Yao W; Sun G; Wang J; Sun Z
    Transplant Cell Ther; 2023 Aug; 29(8):507.e1-507.e8. PubMed ID: 37116582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
    Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study.
    Zhang Y; Chen X; Yang D; Pang A; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Feng S
    Front Immunol; 2022; 13():1004787. PubMed ID: 36172387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.
    Sivgin S; Baldane S; Akyol G; Keklik M; Kaynar L; Kurnaz F; Pala C; Zararsiz G; Cetin M; Eser B; Unal A
    Transfus Apher Sci; 2013 Oct; 49(2):295-301. PubMed ID: 23916904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia.
    Zhang X; Shi Y; Huang Y; Zhang G; He Y; Jiang E; Wei J; Yang D; Ma Q; Zhang R; Zhai W; Feng S; Han M
    Hematology; 2018 Jun; 23(5):291-298. PubMed ID: 29046127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis on the impact of pretransplant iron overload on allogeneic hematopoietic stem cell transplantation for patients with acquired severe aplastic anemia in pediatric].
    Yan L; Xiong H; Long F; Chen Z; Wang Z; Yang L; Tao F; Chen Y; Song N; Wu M
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jun; 45(6):586-590. PubMed ID: 39134491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.
    Liu L; Miao M; He H; Wang S; Zhang Y; Guo A; Jiao W; Lei M; Cai Y; Shangguan X; Liu Z; Xu J; Li X; Zhang L; Wu D
    Front Immunol; 2022; 13():955095. PubMed ID: 36131940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation.
    Wu L; Zhou M; Li Y; Chen X; Mo W; Wang C; Xu S; Zhou W; Deng T; Zhou R; Pan S; Wang S; Zhang Y
    Transplant Cell Ther; 2023 Jul; 29(7):463.e1-463.e7. PubMed ID: 37098408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pretransplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescents.
    Lin F; Zuo Y; Zhang Y; Cheng Y; Han T; Mo X; Suo P; Sun Y; Tang F; Wang F; Yan C; Chen Y; Han W; Wang J; Wang Y; Zhang X; Liu K; Huang X; Xu L
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29845. PubMed ID: 35731841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.
    Lee SE; Yahng SA; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Lee S; Cho SG; Kim DW; Min WS; Lee JW
    Bone Marrow Transplant; 2016 Oct; 51(10):1323-1329. PubMed ID: 27214082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
    Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
    Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-
    Devillier R; Eikema DJ; Dufour C; Aljurf M; Wu D; Maschan A; Kulagin A; Halkes CJM; Collin M; Snowden J; Renard C; Ganser A; Sykora KW; Gibson BE; Maertens J; Itäla-Remes M; Corti P; Cornelissen J; Bornhäuser M; Araujo MC; Ozdogu H; Risitano A; Socie G; De Latour RP
    Haematologica; 2023 Sep; 108(9):2305-2315. PubMed ID: 36951165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of iron chelation therapy on allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome patients with iron overload].
    Gu CH; Li CX; Ye L; Liu H; Ma JF; Wang T; Zou Q; Chen J; Chen XC; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):189-93. PubMed ID: 27033754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.
    Vallejo C; Batlle M; Vázquez L; Solano C; Sampol A; Duarte R; Hernández D; López J; Rovira M; Jiménez S; Valcárcel D; Belloch V; Jiménez M; Jarque I;
    Haematologica; 2014 Oct; 99(10):1632-7. PubMed ID: 24997153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.